The Online Investor
Daily M&A
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com



Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Tue., Mar. 19, 12:53 AM

Slide #2. Bristol Myers Squibb Karuna Therapeutics, Inc.

Acquirer: Bristol Myers Squibb (NYSE:BMY)
Acquiree: Karuna Therapeutics, Inc.
Details: Bristol Myers Squibb (NYSE:BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. ("Karuna"). With the acquisition's completion, Karuna shares have ceased trading on the Nasdaq Global Select Market and Karuna is now a wholly owned subsidiary of Bristol Myers Squibb ("BMS").

Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s pharmaceutical products include chemically-synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor T-cell therapies. Co.'s primary product includes Eliquis® - Eliquis (apixaban), which is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.

Bristol-Myers Squibb SEC Filing Email Alerts Service

Preferred: BMYMP



Open the BMY Page at The Online Investor »

Company Name:  Bristol Myers Squibb Co.
Stock buyback:  BMY buyback
Website:  www.bms.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding BMY:  125
Total Market Value Held by ETFs:  $14.58B
Total Market Capitalization:  $106.14B
% of Market Cap. Held by ETFs:  13.74%
 

Open the BMY Page at The Online Investor (in a new window) »

March 19, 2024    12:53 AM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree BMY Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.30 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)

Analysts' Target Price:
BMY Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Mergers & Acquisitions | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.